Navigation Links
ADHD Genes Found; Known to Play Roles in Neurodevelopment
Date:6/23/2009

-- Missing DNA Segments May Suggest Future Drug Targets --

PHILADELPHIA, June 23 /PRNewswire-USNewswire/ -- Pediatric researchers have identified hundreds of gene variations that occur more frequently in children with attention-deficit hyperactivity disorder (ADHD) than in children without ADHD. Many of those genes were already known to be important for learning, behavior, brain function and neurodevelopment, but had not been previously associated with ADHD.

"Because the gene alterations we found are involved in the development of the nervous system, they may eventually guide researchers to better targets in designing early intervention for children with ADHD," said lead author Josephine Elia, M.D., a psychiatrist and ADHD expert at The Children's Hospital of Philadelphia.

The study appeared online today in the journal Molecular Psychiatry.

Unlike changes to single DNA bases, called SNPs or "snips," the alterations examined in the current study are broader changes in structure. Called copy number variations (CNVs), they are missing or repeated stretches of DNA. CNVs have recently been found to play significant roles in many diseases, including autism and schizophrenia Everyone has CNVs in their DNA, but not all of the variations occur in locations that affect the function of a gene. The current study is the first to investigate the role of CNVs in ADHD.

Individually, each CNV may be rare, but taken together, a combination of changes in crucial regions may interact to raise an individual's risk for a specific disease. "When we began this study in 2003, we expected to find a handful of genes that predispose a child to ADHD," said study co-leader Peter S. White, Ph.D., a molecular geneticist and director of the Center for Biomedical Informatics at Children's Hospital. "Instead, there may be hundreds of genes involved, only some of which are changed in each person.
'/>"/>

SOURCE The Children's Hospital of Philadelphia
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. National Jewish, Brigham and Womens Awarded $37 Million to Identify Genes and Other Risk Factors that Influence the Development of COPD
2. KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model
3. Intradigm Study Shows Ability of siRNAs Systemically Delivered With TargeTran(TM) System to Suppress Tumor-Induced Angiogenesis in Mice
4. Interim Analysis Supports Continuation of Cell Genesys VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
5. Steps Toward Stopping Autoimmune Disease: International Consortium Identifies Genes Linked to Lupus
6. Genomic Health Announces Identification of Genes Associated With Colon Cancer Recurrence Across Multiple Studies
7. ADVENTRX to Present ANX-201 Preclinical Data at Keystone Symposia HIV Pathogenesis Conference
8. deCODE Launches a DNA-Based Test for Assessing Risk of Prostate Cancer on the Back of the Discovery of New Prostate Cancer Genes
9. Cell Genesys Reports Association Between Immune Response and Patient Survival in Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer
10. CorMatrix(R) Announces Intramyocardial Injection of Emulsified ECM Technology(TM) Demonstrates Enhanced Angiogenesis and Improved Cardiac Function in a Preclinical Model
11. Transgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...AGO and STAFA, Switzerland, Nov. 25 /PRNewswire/ -...cturer of innovative hearing solutions, presented ...Conference, focusing on the special needs of the o...eading experts in aging and audiology from around ...eryday with older people with hearing loss for an ...
(Date:11/25/2009)...RDOVA,Calif.,Nov.25/PRNewswire/--AMPACFineChemical...Nasdaq: APFC )announcedtodaythatitreceivedtheEnvir...nnualStatewideEnvironmentalSummit,sponsoredbytheCa...),theIndustrialEnvironmentalAssociation(IEA)andthe...Diego.Thisisthemostprestigiousawardavailablefromal...
(Date:11/25/2009)... CITY, Calif., Nov. 25 A...ompany manufacturing point-of-care blood analysis ...rman and chief executive officer, will present at ...ce on Wednesday, December 2, 2009 at 2:00 p.m. ET....e Hotel in New York City. ,, About Abaxis ,...
Breaking Medicine Technology:Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2Thomson Reuters Invites You to the First Latin American Forum Covering the Pharmaceutical Industry 54437 1Thomson Reuters Invites You to the First Latin American Forum Covering the Pharmaceutical Industry 54437 2Perrigo Company Announces Quarterly Dividend 54432 1International robotic surgery forum launches in Chicago 54428 1International robotic surgery forum launches in Chicago 54428 2
...Threshold,Pharmaceuticals, Inc. (Nasdaq: THLD ), ...of glufosfamide plus gemcitabine were presented at...ing in Barcelona, Spain. In the Phase 2 clinical ...ine for the treatment of advanced pancreatic cance...I: 31-67%) and 32% (95% CI: 16 - 49%),respectively...
...hase 1a SAD Clinical Study -, BRISBANE, Calif., S...d that the company has begun dosing the first,pati...D) clinical trial,evaluating ITMN-191 (also called...-191 is a hepatitis C virus (HCV) protease inhibit...che. InterMune also reported additional,informatio...
Other Medicine Technology:Positive Glufosfamide Results From a Phase 2 Clinical Trial Presented at European Cancer Conference (ECCO) 2Positive Glufosfamide Results From a Phase 2 Clinical Trial Presented at European Cancer Conference (ECCO) 3Positive Glufosfamide Results From a Phase 2 Clinical Trial Presented at European Cancer Conference (ECCO) 4InterMune Announces Start of Phase 1b Trial of ITMN-191 2InterMune Announces Start of Phase 1b Trial of ITMN-191 3InterMune Announces Start of Phase 1b Trial of ITMN-191 4
(Date:11/26/2009)...the number of Americans living with diabetes will ...9 to 44.1 million in 2034. Over the same period, s...m $113 billion to $336 billion, even with no incre...d at the University of Chicago report in the Decem...ose with diabetes covered by Medicare will rise fr...
(Date:11/26/2009)... No more letters from the North Pole, Textsanta.n...ages from Santa , North P...ional efficiencies at the North Pole Santa Claus h...all over the globe informed of his Christmas progr...research department have identified a large and gr...
(Date:11/26/2009)... Ennis & Ennis, P.A. is offering free nationw...d Yasmin birth control pills who have suffered a D...oke, Heart Attack or other related cardiac issues ...oll free at 1-800-856-6405 or go to the firm&rsquo...ut an online case evaluation form. , ...
(Date:11/25/2009)...Y,Nov.25/PRNewswire/-SentinelleMedicalInc.,aleadin...ndsoftwareandCalgaryScientificInc.,aleadingprovide...versionofAegis(TM)Breast4DAdvancedVisualizationsof...yzero-footprintWebclientbasedmedicalimagingofferin...mallowsforzero-footprintaccess-requiringnosoftware...
(Date:11/25/2009)...S, Nov. 25 The Black AI...ions to determine executive leadership for 2010. ,...oup of leaders with specialties in public policy, ...l, and business entrepreneurship. The Board also c...luding both heterosexual and gay Black men and wom...
Breaking Medicine News(10 mins):Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2
...arch 5 Relax The Back corporation,sold a record n...ficials,have announced 16 franchised locations wer...ives note that 2008 is shaping up to deliver simil...company,s long-term goal is to operate 300 to 320 ...
...arch 5 Parker Waichman Alonso LLP,announces that ...h,Nephrogenic Systemic Fibrosis (NSF) after receiv...ast dye manufactured by General Electric,Company, ...tients with pre-existing kidney disease who have b...
... Family Members Confront Lazard Execs, Protest,Out...RK, March 5 Workers, family members of,elderly re...ealthcare,members confronted private equity owner ...country., Atria -- the third-largest assisted liv...
...lif., March 5 Hundreds of,patients who rely on Co...Mission campus for medical services will be forced... The hospital will shut down the Pediatric and Ob...nt care operations,last year., The Huntington Par...
...enter of ability to control impulsive responses, s...Day News) -- Teens at risk of developing a substan...ctivation, a U.S. study concludes. , The research...en increased risk for a substance abuse disorder a...
...ation modifications to the structure of chromatin...l is a key player in embryonic development and ca...lar Biology Laboratory [EMBL] in Heidelberg now ga...at estrogen causes rapid epigenetic changes in bre...
Other Medicine News:Health News:Relax The Back Announces Record Growth in 2007; Executives Bullish on Specialty Retailer's Prospects for 2008 2Health News:Parker Waichman Alonso LLP Files Suit Against General Electric Company on Behalf of a Man Who Developed Nephrogenic Systemic Fibrosis (NSF) from Contrast Agent Omniscan 2Health News:Parker Waichman Alonso LLP Files Suit Against General Electric Company on Behalf of a Man Who Developed Nephrogenic Systemic Fibrosis (NSF) from Contrast Agent Omniscan 3Health News:New! Pull Back the Corporate Curtain at www.LazardUnveiled.org 2Health News:Community & Mission Hospital of Huntington Park Shutting Down Mission Campus, Terminating Workers 2Health News:Deficit in Brain Function Puts Teens at Risk of Drug Abuse 2Health News:New revelations in epigenetic control shed light on breast cancer 2
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
Medicine Products: